Orion and Sun settle US Stalevo and Comtan patent suits
This article was originally published in Scrip
Executive Summary
Sun Pharma will be able to launch generic versions of Orion's Parkinson's disease treatments, Stalevo and Comtan, in the US by April 2012 and April 2013 respectively, as part of a patent litigation settlement between the two companies.